RPR 106541, a novel, airways-selective glucocorticoid: effects against antigen-induced CD4~+ T lymphocyte accumulation and cytokine gene expression in the Brown Norway rat lung

摘要

The high topical potency of RPR 10651 in this model, which minics important aspects of airway inflammation in human allergic asthmatics, suggests that this glucocorticoid may be useful in the treatment of bronchial asthma.